A novel oncolytic virus-based biomarker participates in prognosis and tumor immune infiltration of glioma

BACKGROUND: Glioma is the most common central nervous malignancy. Due to its poor survival outcomes, it is essential to identify novel individualized therapy. Oncolytic virus (OV) treatment is a key therapy regulating tumor microenvironment in malignant glioma. Herein, we aim to identify the key gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Zheng, Yin, Xiaofeng, Ding, Rui, Chen, Laizhao, Hao, Chunyan, Duan, Hubin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556503/
https://www.ncbi.nlm.nih.gov/pubmed/37808305
http://dx.doi.org/10.3389/fmicb.2023.1249289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556503/
https://www.ncbi.nlm.nih.gov/pubmed/37808305
http://dx.doi.org/10.3389/fmicb.2023.1249289

Ejemplares similares